TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of a Strength and Neuromuscular Exercise Programme for the Lower Extremity on Knee Load, Pain and Function in Obese Children and Adolescents: a Randomised, Single-blinded Controlled Trial
Brief Summary: Childhood obesity is one of the most critical and accelerating health challenges throughout the world. It is a major risk factor for developing varus/valgus misalignments of the knee joint. The combination of misalignment at the knee and excess body mass may result in increased joint stress and damage to articular cartilage. A training programme, which aims at developing a more neutral alignment of the trunk and lower limbs during movement tasks may be able to reduce knee loading during locomotion. Despite the large number of guidelines for muscle strength training and neuromuscular exercises that exists, most are not specifically designed to target the obese children and adolescent demographic.

The purpose of this study is to evaluate a training programme which combines strength and neuromuscular exercises specifically designed to the needs and limitations of obese children and adolescents and analyse the effects of the training programme from a biomechanical and clinical point of view.


Options:
A: Arm Label: Chiropractic + Exercise; Type: EXPERIMENTAL; Interventions: Other: Chiropractic + Exercise | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Chiropractic + Exercise; Assigned to Arm(s): Chiropractic + Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise
B: Arm Label: Treatment with manipulation; Type: EXPERIMENTAL; Interventions: Procedure: Advice and exercise-based treatment plus joint manipulation | Arm Label: Treatment without manipulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Advice and exercise-based treatment | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment plus joint manipulation; Assigned to Arm(s): Treatment with manipulation | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment; Assigned to Arm(s): Treatment without manipulation
C: Arm Label: Education Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Pain Self-Management Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Pain self-management, Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Pain self-management; Assigned to Arm(s): Pain Self-Management Intervention | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education Control, Pain Self-Management Intervention
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Strength and neuromuscular exercise programme | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Strength and neuromuscular exercise programme; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase 3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects
Brief Summary: The purpose of this study is to evaluate the effects of of rosuvastatin 20 mg compared to placebo for treating Chinese patients with subclinical atherosclerosis.


Options:
A: Intervention Type: DRUG; Name: chlorthalidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atenolol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: reserpine; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: lovastatin; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: torcetrapib/atorvastatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): N/A
D: Arm Label: Rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase 3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects
Brief Summary: The purpose of this study is to evaluate the effects of of rosuvastatin 20 mg compared to placebo for treating Chinese patients with subclinical atherosclerosis.


Options:
A: Intervention Type: DRUG; Name: chlorthalidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atenolol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: reserpine; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pitavastatin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pitavastatin | Intervention Type: DRUG; Name: Pitavastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Pitavastatin; Assigned to Arm(s): 2
C: Arm Label: Rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Rosuvastatin | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase 3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects
Brief Summary: The purpose of this study is to evaluate the effects of of rosuvastatin 20 mg compared to placebo for treating Chinese patients with subclinical atherosclerosis.


Options:
A: Arm Label: MED-Cohort; Type: N/A; Interventions: Drug: Low Molecular Weight Heparin | Arm Label: ICU-Cohort; Type: N/A; Interventions: Drug: Low Molecular Weight Heparin | Intervention Type: DRUG; Name: Low Molecular Weight Heparin; Assigned to Arm(s): ICU-Cohort, MED-Cohort
B: Arm Label: Therapeutic Dose Anticoagulation; Type: OTHER; Interventions: Drug: theraputic heparin | Arm Label: Prophylactic Dose Anticoagulation; Type: OTHER; Interventions: Drug: prophylactic heparin | Arm Label: Therapeutic Dose Anticoagulation + P2Y12 inhibitor; Type: OTHER; Interventions: Drug: theraputic heparin, Drug: P2Y12 | Arm Label: Prophylactic Dose Anticoagulation + P2Y12 inhibitor; Type: OTHER; Interventions: Drug: prophylactic heparin, Drug: P2Y12 | Arm Label: Standard of Care + Crizanlizumab; Type: OTHER; Interventions: Drug: Crizanlizumab Injection | Arm Label: Standard of Care + SGLT2 inhibitor; Type: OTHER; Interventions: Drug: SGLT2 inhibitor | Arm Label: Standard of Care (SGLT2 arm); Type: OTHER; Interventions: Drug: SGLT2 inhibitor | Arm Label: Standard of Care (Criza); Type: OTHER; Interventions: Drug: Crizanlizumab Injection | Intervention Type: DRUG; Name: theraputic heparin; Assigned to Arm(s): Therapeutic Dose Anticoagulation, Therapeutic Dose Anticoagulation + P2Y12 inhibitor | Intervention Type: DRUG; Name: prophylactic heparin; Assigned to Arm(s): Prophylactic Dose Anticoagulation, Prophylactic Dose Anticoagulation + P2Y12 inhibitor | Intervention Type: DRUG; Name: P2Y12; Assigned to Arm(s): Prophylactic Dose Anticoagulation + P2Y12 inhibitor, Therapeutic Dose Anticoagulation + P2Y12 inhibitor | Intervention Type: DRUG; Name: Crizanlizumab Injection; Assigned to Arm(s): Standard of Care (Criza), Standard of Care + Crizanlizumab | Intervention Type: DRUG; Name: SGLT2 inhibitor; Assigned to Arm(s): Standard of Care (SGLT2 arm), Standard of Care + SGLT2 inhibitor
C: Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: lovastatin; Assigned to Arm(s): N/A
D: Arm Label: Rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Brief Summary: The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent studies have associated solutions with supraphysiologic chloride content with hyperchloremia, metabolic acidosis and renal vasoconstriction, acute kidney injury and renal replacement therapy, and increased mortality but no large, randomized-controlled trials have been conducted. SMART-SURG will be a large, cluster-randomized, multiple-crossover trial enrolling critically ill patients from the non-medical ICUs at Vanderbilt University from October 2015 until April 2017. The primary endpoint will be the incidence of Major Adverse Kidney Events in 30 days after enrollment (MAKE30 is the composite of death, new renal replacement, or persistent renal dysfunction at discharge).


Options:
A: Arm Label: Plasma-Lyte, Slow Infusion; Type: EXPERIMENTAL; Interventions: Drug: Plasma-Lyte, Other: Slow infusion speed | Arm Label: Plasma-Lyte, Fast Infusion; Type: EXPERIMENTAL; Interventions: Drug: Plasma-Lyte, Other: Fast Infusion Speed | Arm Label: Saline 0.9%, Slow Infusion; Type: EXPERIMENTAL; Interventions: Drug: Saline 0.9%, Other: Slow infusion speed | Arm Label: Saline 0.9%, Fast Infusion; Type: EXPERIMENTAL; Interventions: Drug: Saline 0.9%, Other: Fast Infusion Speed | Intervention Type: DRUG; Name: Plasma-Lyte; Assigned to Arm(s): Plasma-Lyte, Fast Infusion, Plasma-Lyte, Slow Infusion | Intervention Type: DRUG; Name: Saline 0.9%; Assigned to Arm(s): Saline 0.9%, Fast Infusion, Saline 0.9%, Slow Infusion | Intervention Type: OTHER; Name: Slow infusion speed; Assigned to Arm(s): Plasma-Lyte, Slow Infusion, Saline 0.9%, Slow Infusion | Intervention Type: OTHER; Name: Fast Infusion Speed; Assigned to Arm(s): Plasma-Lyte, Fast Infusion, Saline 0.9%, Fast Infusion
B: Arm Label: 0.9% Saline; Type: ACTIVE_COMPARATOR; Interventions: Other: 0.9% Saline | Arm Label: Physiologically-balanced; Type: ACTIVE_COMPARATOR; Interventions: Other: Physiologically-balanced isotonic crystalloid | Intervention Type: OTHER; Name: 0.9% Saline; Assigned to Arm(s): 0.9% Saline | Intervention Type: OTHER; Name: Physiologically-balanced isotonic crystalloid; Assigned to Arm(s): Physiologically-balanced
C: Arm Label: 0.9% Saline; Type: ACTIVE_COMPARATOR; Interventions: Other: 0.9% Saline | Arm Label: Physiologically-balanced; Type: ACTIVE_COMPARATOR; Interventions: Other: Physiologically-balanced isotonic crystalloid | Intervention Type: OTHER; Name: 0.9% Saline; Assigned to Arm(s): 0.9% Saline | Intervention Type: OTHER; Name: Physiologically-balanced isotonic crystalloid; Assigned to Arm(s): Physiologically-balanced
D: Arm Label: Adult ICU patient receiving Fluid resus; Type: N/A; Interventions: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhancing Physical Activity and Weight Reduction Through Smartcare and Financial Incentives: A Pilot Randomized Controlled Trial
Brief Summary: The investigators are planning to conduct a pilot RCT of young obese population to evaluate the effect of smartcare with or without financial incentives for 12 weeks. Participants will be randomly assigned to a three-arm of control, smartcare, and smartcare plus financial incentives group.


Options:
A: Arm Label: Intensive digital CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Standard digital CBT; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-guided | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Intensive digital CBT | Intervention Type: DEVICE; Name: Self-guided; Assigned to Arm(s): Standard digital CBT
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: smartcare; Type: ACTIVE_COMPARATOR; Interventions: Device: smartcare | Arm Label: smartcare plus financial incentives; Type: ACTIVE_COMPARATOR; Interventions: Device: smartcare, Other: financial incentives | Intervention Type: DEVICE; Name: smartcare; Assigned to Arm(s): smartcare, smartcare plus financial incentives | Intervention Type: OTHER; Name: financial incentives; Assigned to Arm(s): smartcare plus financial incentives
C: Arm Label: Podcast (+Bite Counter); Type: EXPERIMENTAL; Interventions: Behavioral: Podcasts, Behavioral: Bite Counter | Arm Label: Podcast (+Mobile App); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Podcasts, Behavioral: Mobile Diet Application | Intervention Type: BEHAVIORAL; Name: Podcasts; Assigned to Arm(s): Podcast (+Bite Counter), Podcast (+Mobile App) | Intervention Type: BEHAVIORAL; Name: Mobile Diet Application; Assigned to Arm(s): Podcast (+Mobile App) | Intervention Type: BEHAVIORAL; Name: Bite Counter; Assigned to Arm(s): Podcast (+Bite Counter)
D: Arm Label: Physical Activity; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity | Arm Label: Wellness Contact Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Physical Activity | Intervention Type: BEHAVIORAL; Name: Wellness; Assigned to Arm(s): Wellness Contact Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D Status in the First 9 Months of Life
Brief Summary: In this study the investigators wanted to assess vitamin D status and possible consequences of low plasma 25-hydroxyvitamin D levels in a population of healthy mothers and their infants, in the community of Aarhus, Denmark.


Options:
A: Arm Label: Vitamin D 150,000 units once; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Vitamin D 5000 units daily; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D 150,000 units once | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D 5000 units daily
B: Arm Label: vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): vitamin D | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
C: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo control | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo control; Assigned to Arm(s): Control
D: Intervention Type: OTHER; Name: Blood and breastmilk samples; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Brief Summary: The purpose of this study is to assess the efficacy of dexmedetomidine versus propofol for prolonged sedation in trauma and surgical patients.


Options:
A: Arm Label: delirious patients; Type: N/A; Interventions: N/A | Arm Label: non-delirious patients; Type: N/A; Interventions: N/A
B: Arm Label: PS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized Sedation | Arm Label: PS + DI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized sedation, with daily interruption | Intervention Type: PROCEDURE; Name: Protocolized Sedation; Assigned to Arm(s): PS | Intervention Type: PROCEDURE; Name: Protocolized sedation, with daily interruption; Assigned to Arm(s): PS + DI
C: Arm Label: dexmedetomidine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexmedetomidine | Arm Label: propofol group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): dexmedetomidine group
D: Arm Label: Haloperidol 1mg/q8h; Type: EXPERIMENTAL; Interventions: Drug: Haloperidol 1 mg/q8h | Arm Label: Haloperidol 2mg/q8h; Type: EXPERIMENTAL; Interventions: Drug: Haloperidol 2 mg/q8h | Arm Label: Sodium chloride 0.9%; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Haloperidol 1 mg/q8h; Assigned to Arm(s): Haloperidol 1mg/q8h | Intervention Type: DRUG; Name: Haloperidol 2 mg/q8h; Assigned to Arm(s): Haloperidol 2mg/q8h | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sodium chloride 0.9%

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Radial Artery Cathetrization, A Novel Technique.
Brief Summary: Comparing an novel technique ( oblique view) during ultrasound guided radial artery catheterization versus Transverse and longitudinal views


Options:
A: Arm Label: Palpation only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RAP palpation only | Arm Label: Ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: RAP with ultrasound guidance | Intervention Type: PROCEDURE; Name: RAP palpation only; Assigned to Arm(s): Palpation only | Intervention Type: PROCEDURE; Name: RAP with ultrasound guidance; Assigned to Arm(s): Ultrasound guidance
B: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group
C: Arm Label: Dynamic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dynamic | Arm Label: Regular-triangle; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Regular-triangle | Intervention Type: BEHAVIORAL; Name: dynamic; Assigned to Arm(s): Dynamic | Intervention Type: BEHAVIORAL; Name: Regular-triangle; Assigned to Arm(s): Regular-triangle
D: Arm Label: With ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: Artery puncture with ultrasound guidance | Arm Label: Without ultrasound guidance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Artery puncture without ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture with ultrasound guidance; Assigned to Arm(s): With ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture without ultrasound guidance; Assigned to Arm(s): Without ultrasound guidance

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Radial Artery Cathetrization, A Novel Technique.
Brief Summary: Comparing an novel technique ( oblique view) during ultrasound guided radial artery catheterization versus Transverse and longitudinal views


Options:
A: Arm Label: Ultrasound radial artery catheter; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided radial artery catheterization. | Arm Label: Palpation based artery catheterization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blind insertion of radial artery catheterization | Intervention Type: PROCEDURE; Name: Ultrasound guided radial artery catheterization.; Assigned to Arm(s): Ultrasound radial artery catheter | Intervention Type: PROCEDURE; Name: Blind insertion of radial artery catheterization; Assigned to Arm(s): Palpation based artery catheterization
B: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG
C: Arm Label: Radial access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial Access | Arm Label: State-of-the-art femoral access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: State-of-the-art femoral access with 18 gauge needle, Procedure: State-of-the-art femoral access with 21 gauge needle | Intervention Type: PROCEDURE; Name: Radial Access; Assigned to Arm(s): Radial access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 18 gauge needle; Assigned to Arm(s): State-of-the-art femoral access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 21 gauge needle; Assigned to Arm(s): State-of-the-art femoral access
D: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Radial Artery Cathetrization, A Novel Technique.
Brief Summary: Comparing an novel technique ( oblique view) during ultrasound guided radial artery catheterization versus Transverse and longitudinal views


Options:
A: Arm Label: With ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: Artery puncture with ultrasound guidance | Arm Label: Without ultrasound guidance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Artery puncture without ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture with ultrasound guidance; Assigned to Arm(s): With ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture without ultrasound guidance; Assigned to Arm(s): Without ultrasound guidance
B: Arm Label: Ultrasound guided arterial puncture; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided arterial puncture | Arm Label: Conventional arterial puncture technique; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional arterial puncture technique | Intervention Type: PROCEDURE; Name: Ultrasound guided arterial puncture; Assigned to Arm(s): Ultrasound guided arterial puncture | Intervention Type: PROCEDURE; Name: Conventional arterial puncture technique; Assigned to Arm(s): Conventional arterial puncture technique
C: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group
D: Arm Label: Arterial catheter; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Arm Label: Placement; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Intervention Type: PROCEDURE; Name: Laying a radial or femoral arterial catheter; Assigned to Arm(s): Arterial catheter, Placement

Answer: C